diphenylcyclopropenone has been researched along with tacrolimus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hengge, UR; Meykadeh, N | 1 |
| Hunter, N; Marei, N; Shaker, O | 1 |
1 trial(s) available for diphenylcyclopropenone and tacrolimus
| Article | Year |
|---|---|
Diphencyprone and topical tacrolimus as two topical immunotherapeutic modalities. Are they effective in the treatment of alopecia areata among Egyptian patients? A study using CD4, CD8 and MHC II as markers.
Topics: Administration, Topical; Adolescent; Adult; Alopecia Areata; Antibodies, Monoclonal; Biomarkers; CD4 Antigens; CD8 Antigens; Child; Cyclopropanes; Egypt; Female; Histocompatibility Antigens Class II; Humans; Immunohistochemistry; Immunosuppressive Agents; Male; Scalp Dermatoses; T-Lymphocyte Subsets; Tacrolimus; Treatment Outcome; Young Adult | 2011 |
1 other study(ies) available for diphenylcyclopropenone and tacrolimus
| Article | Year |
|---|---|
[Topical immunomodulators in dermatology].
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts | 2003 |